Without enough glutathione, your body struggles to neutralize free radicals, resulting in dull skin, dark spots, fine lines, and low energy
Drugs such as semaglutide are an important and valid weight management tool for those living with or at risk of type 2 diabetes, and people should be supported to find the approach that is most appropriate for them. In August, Novo Nordisk published the findings of its own five-year study on Wegovy, known as the Select trial
The obesity and metabolic disease market continues to be a high-growth area, with the global obesity drug market projected to reach $150 billion by 2035, according to a recent analysis by Clarivate, a business intelligence firm serving the bio/pharmaceutical industry
Those who view the transition as a temporary adjustment phase within a long-term weight management journey typically persist through difficulties and achieve good outcomes